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DObjectives: We sought to describe the prevalence of restrictive lung function in structural congenital heart
disease and to determine the effect of cardiothoracic surgical intervention.
Methods: The data from a retrospective review of the spirometry findings from pediatric patients with structural
congenital heart disease were compared with the data from 220 matched controls. Restrictive lung function was
defined as a forced vital capacity of<80%, with a preserved ratio of the forced expiratory volume in the first
second to forced vital capacity of>80%.
Results: Of the children with congenital heart disease, 20% met the criteria for restrictive lung function
compared with 13.2% of the controls (P ¼ .03). The prevalence in those with congenital heart disease without
a surgical history was similar to that of the controls (odds ratio, 0.62; 95% confidence interval, 0.34-1.13).
Restrictive lung function was more likely if surgical intervention had occurred within the first year of life
(odds ratio, 1.96; 95% confidence interval, 1.08-3.55; P<.0001). Those who had undergone both sternotomy
and thoracotomy had a greater prevalence of restrictive lung function than those who had undergone sternotomy
or thoracotomy alone (54.2% vs 25.6% and 23.5%, respectively; P<.0001). The prevalence of restrictive lung
function increased significantly with each additional surgical intervention (odds ratio, 1.61; 95% confidence
interval, 1.29-2.01; P<.0001).
Conclusions: Restrictive lung function was more prevalent in those with congenital heart disease after cardio-
thoracic surgical intervention than in the controls or patients without surgical intervention. The prevalence was
also greater with surgical intervention at an earlier age. The risk was equivalent when sternotomy alone was
compared with thoracotomy alone but was significantly greater when both sternotomy and thoracotomy
were performed. The risk increased with each additional surgery performed. (J Thorac Cardiovasc Surg
2014;148:207-11)Restrictive lung disease is associated with intrinsic lung dis-
eases that lead to inflammation and scarring of the lung pa-
renchyma and with extrinsic lung diseases that lead to lung
restriction and impaired respiration. A restrictive pattern
has been shown to be associated with certain forms of struc-
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The Journal of Thoracic and Castudies.1-14 To our knowledge, pulmonary function testing
in a large pediatric population with CHD has never been
studied. In our clinical practice, it has been observed that
patients with structural CHD, especially those who have
undergone surgical intervention, are more likely to have a
pattern of restrictive lung function (RLF) on spirometry
consistent with restrictive lung disease. In those who do
develop RLF, it has been unclear whether this has been
related to the specific heart lesion, cardiothoracic surgical
intervention, the type of surgical approach (sternotomy vs
thoracotomy), or some other unrecognized etiology.
Since 2002, our center has routinely obtained spirom-
etry testing for all patients before they undergo cardiopul-
monary exercise testing (CPET). This has resulted in a
unique database of pulmonary function testing for hun-
dreds of pediatric patients with CHD who were able to un-
dergo testing. We sought to describe the prevalence of
RLF in those with CHD, with the hypothesis that RLF
would be more prevalent in patients with structural CHD
than in controls and that those who underwent surgical
intervention for CHD would have a greater prevalence of
RLF than those who did not undergo surgery. Furthermore,
we evaluated whether the age at first surgical intervention,
the number of surgical interventions, and the anatomicrdiovascular Surgery c Volume 148, Number 1 207
Abbreviations and Acronyms
CHD ¼ congenital heart disease
CI ¼ confidence interval
CPET ¼ cardiopulmonary exercise test
FVC ¼ forced vital capacity
FEV1 ¼ forced expiratory volume in 1 s
RLF ¼ restrictive lung function
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Dlocation of the CHD had an effect on the development
of RLF.METHODS
The ColoradoMultiple Institutional Review Board approved the present
single-center retrospective chart review (COMIRB protocol no. 11-0019),
which was performed at our large, academic, pediatric tertiary care center.
The study population included patients with structural CHD who had un-
dergone CPET from December 2002 through January 2011. Patients with
repair of anatomic defects by nonsurgical methods, such as intravascular
intervention, were not included. Patients with nonstructural CHD, such
as arrhythmias, were not considered. The control population was age-
and gender-matched to the patients with CHD and included patients who
had undergone CPET for any reason (eg, exertional dyspnea, chest pain)
but had been found to have structurally normal hearts.
Baseline spirometry and CPET were performed using a metabolic cart
and cycle ergometer (Care Fusion, Yorba Linda, Calif). Spirometry was
performed according to the American Thoracic Society guidelines.15 All
CPET included measurement of metabolic gases, blood pressure, oxygen
saturation, and electrocardiography according to the standard guidelines.16
Spirometry provided the forced vital capacity (FVC), forced expiratory
volume in 1 s (FEV1), and the FEV1/FVC ratio. The FVC and FEV1 are re-
ported as the percentage predicted according to age, gender, and height.
Normal spirometry findings were defined as FVC, FEV1, and FEV1/FVC
ratio>80% of the predicted value according to age, gender, and height.
RLF was defined as a reduced FVC of<80% predicted, with a preserved
FEV1/FVC ratio>80%.
17
A total of 1163 cases of pediatric patients with structural CHD who had
undergone spirometry and CPET were available. The test results were
excluded if poor patient technique during spirometry had been documented
or incomplete data had been documented during the test. This resulted in
677 pediatric patients with CHD with 876 complete test results available
for analysis. Many patients with CHD underwent several sessions of
CPET and spirometry during the study period as part of their overall clin-
ical management. Only the most recent test result was evaluated, unless
otherwise specified.
The CHD population was subdivided into groups according to the
anatomic location of the pathologic entity for the purpose of comparing le-
sions of dissimilar pathophysiology. The groups included left-sided lesions,
right-sided lesions, septal defects, and other primary lesions. The surgical
approach (ie, sternotomy or thoracotomy, or both), patient age at the first
surgical intervention, and the total number of surgical interventions were
recorded.
Statistical analyses were performed using Statistical Analysis Systems
(SAS Institute, Cary, NC). When longitudinal data needed to be com-
pressed into a single measurement, either the first or last chronological
observation on a subject was used, within a set of criteria that depended
on the specific question. The analyses were conducted using the available
case data. Categorical variables were compared using 2-way frequency ta-
bles and chi-square and Fisher’s exact association tests. For binary out-
comes, logistic regression analysis was sometimes used. Proportions and208 The Journal of Thoracic and Cardiovascular Surgodds ratios were computed, as needed. For continuous variables, standard
descriptive statistics, such as the mean and standard deviation are pre-
sented. Because of the longitudinal nature of the data, mixed models
regression methods were used for inferential statistics.RESULTS
Data from the CHD and control populations included in
the present study are listed in Table 1. Overall, the patients
with CHD had a greater prevalence of RLF than did the con-
trols (19.7% vs 13.2%), with a definite association between
CHD and RLF (P¼ .03). When the patients with CHDwere
further divided into nonsurgical and surgical groups, a
significantly greater prevalence of RLF was found in the
postoperative CHD group (25.5%) than in the control group
(13.2%) and nonsurgical CHD group (8.6%; P< .0001;
Table 2). The odds ratio of RLF in the surgical CHD popu-
lation compared with the nonsurgical CHD population and
the control population was 3.64 (95% confidence interval
[CI], 2.19-6.03) and 2.25 (95% CI, 1.44-3.51), respectively.
The risk of RLF in the nonsurgical CHD group was not
different from that of the controls (odds ratio, 0.62; 95%
CI, 0.34-1.13).
The nonsurgical CHD group (233 patients who per-
formed 244 tests) was stratified according to the anatomic
location of the primary defect to assess whether RLF was
associated with lesion type. The groups included left-
sided lesions (n ¼ 98), right-sided lesions (n ¼ 41), septal
defects (n ¼ 32), and other lesions (n ¼ 72). The analysis
was limited to those patients who had undergone no surgical
intervention before CPET to avoid surgical intervention as a
confounding factor. Although RLF was somewhat more
prevalent in left-sided (11.2%) than in right-sided lesions
(7.3%), RLF was not significantly associated with lesion
type in the nonsurgical population (P ¼ .96).
Included in the nonsurgical CHD group were 11 patients
who had previously undergone transcatheter intervention
for their CHD. These included 5 patients who had under-
gone transcatheter device closure of an atrial septal defect,
4 patients with aortic coarctation stenting, and 2 patients
with aortic coarctation balloon angioplasty. Of these 11 pa-
tients, 1 with atrial septal defect closure and 1 with balloon
angioplasty demonstrated RLF.
Of the 444 postoperative CHD patients, 390 had clear
documentation of the age at which they had undergone their
first surgical intervention. The subanalysis demonstrated
that the prevalence of RLF was greater when surgical inter-
vention had occurred before 1 year of age (30.2%)
compared with intervention after 1 year of age (18.1%).
However, surgical intervention before 1 month of age did
not greatly increase the prevalence (32.6%; P ¼ .016;
Table 3).
A comparison according to the cardiothoracic surgical
intervention in the CHD population was performed to deter-
mine the effect of the first surgical approach (ie, sternotomyery c July 2014
TABLE 1. Demographics of control and CHD populations
Variable Controls CHD group
Tests (n) 220 876
Male gender (%) 61.1 67.4
Age (y) 13.9  3.3 15.5  7.7
BMI (kg/m2) 21.1  4.4 21.1  6.6
Height (cm) 161.4  15.8 157.9  18.2
Weight (kg) 56.5  18.8 54.3  21.2
CHD, Congenital heart disease; BMI, body mass index.
TABLE 3. Prevalence of RLF stratified by age at first surgical
intervention*
Age at first surgical
intervention Patients (n) RLF (%) 95% CI
<1 mo 46 32.6 24.9-40.4
1 mo to 1 y 35 30.2 21.8-38.5
>1 y 24 18.1 11.5-24.6
RLF, Restrictive lung function; CI, confidence interval. *P ¼ .016; chi-square
association test.
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Dor thoracotomy, or both) on the prevalence of RLF
(Table 4). Of the 444 postoperative patients, 277 had under-
gone sternotomy alone, 81 thoracotomy alone, and 59 both
approaches. One patient was excluded because of an un-
clear surgical status, and 27 had a known surgical history
without clear documentation regarding which surgical
approach had been used. The surgical approach was
significantly associated with the development of RLF
(P<.0001), with the greatest prevalence of RLF seen in pa-
tients who had undergone both sternotomy and thoracotomy
(54.2%). No difference was found in the prevalence of RLF
in the postoperative CHD patients when sternotomy alone
was compared with thoracotomy alone (P ¼ .69).
The influence that the number of surgical interventions an
individual patient had undergone was also evaluated.
Figure 1 demonstrates the effect the number of surgical in-
terventions performed had on the prevalence of RLF, with
more surgical interventions associated with greater rates
of RLF. Despite the low numbers of patients with 3 or 4 sur-
gical interventions, logistic regression analysis demon-
strated that the odds of a patient with CHD having RLF
increased by an estimated 61% (95% CI, 28.9%-101.2%).TABLE 4. Prevalence of RLF stratified by method of first surgical
intervention*DISCUSSION
Our study results have shown that pediatric patients with
structural CHDwere more likely to develop RLF but only in
those who had undergone surgical intervention by sternot-
omy and/or thoracotomy. Surgical intervention at a younger
age was associated with a greater risk, just as was the com-
bination of both sternotomy and thoracotomy at initial sur-
gical intervention. Furthermore, those who had undergone
multiple surgical interventions were even more likely to
develop RLF, with each procedure conferring additional
risk. The anatomic site of CHD was not associated with
RLF in the nonsurgical CHD population.
Ours was not the first study to demonstrate a restrictive
pattern in a population after surgical intervention forTABLE 2. Prevalence of RLF in control and CHD populations*
Variable Controls Nonsurgical CHD Surgical CHD
Total patients (n) 220 233 444
Patients with RLF (n) 29 (13.2) 20 (8.6) 113 (25.5)
Data in parentheses are percentages. RLF, Restrictive Lung function; CHD, congen-
ital heart disease. *P<.0001; chi-square association test.
The Journal of Thoracic and CaCHD. Postoperative pediatric patients with atrial septal de-
fects have been shown to have reduced expiratory reserve
volume and FVC and decreases in lung compliance with
sternotomy compared with percutaneous closure.3,10,11,14
The lung volume and lung compliance have been shown
to be decreased in a number of studies of both pediatric
and adult patients with ventricular septal defects,12 transpo-
sition,7 tetralogy of Fallot,1,2,6,9,18 and post-Fontan5,19
surgical repair.
Several studies have found a lesion-specific prevalence of
RLF without surgical intervention, including in adults with
congenital pulmonary stenosis4 and aortic stenosis.13 In
adults with aortic stenosis, a restrictive pattern was only
seen in those with an elevated pulmonary capillary wedge
pressure. Our data did not support a lesion-specific etiology
for the development of RLF in the nonsurgical CHD pediat-
ric population; however, we grouped the lesions into very
basic anatomic subgroups. Thus, it is possible that certain
lesions such as mitral stenosis behave physiologically
differently than coarctation of the aorta, for example, and
would have a different effect on the development of RLF.
Few studies have demonstrated changes in lung compli-
ance, although Schofield and colleagues8 showed an inverse
relationship among FVC, FEV1, and FEV1/FVC ratio as the
mean pulmonary artery pressure increased in patients with
atrial septal defects, suggesting that cardiopulmonary he-
modynamics do play a role in lung function. The most thor-
ough review of pulmonary function data from patients with
CHD was performed by Pianosi and colleagues,20 who
concluded that changes in pulmonary function were lesion
specific and that surgical intervention played a minimal
role in the development of restriction, unless a complication
leading to diaphragm paresis occurred. These findings
contrasted with our results, which demonstrated a clearFirst surgical intervention Patients (n) RLF (%) 95% CI
Sternotomy 277 25.6 20.5-30.8
Thoracotomy 81 23.5 14.2-32.7
Sternotomy with thoracotomy 59 54.2 41.5-66.9
Unknown 27 — —
RLF, Restrictive lung function; CI, confidence interval. *P < .0001; chi-square
association test.
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FIGURE 1. Logistic regression of the prevalence of restrictive lung
function (RLF) in the congenital heart disease population according to
the number of surgical interventions.
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Dassociation between surgical intervention and the occur-
rence of RLF.
Evidence is conflicting regarding the effect of the point of
the first repair on cardiopulmonary physiology. Samanek
and colleagues7 demonstrated that an earlier age at transpo-
sition of the great arteries correction was associated with a
more pronounced reduction in lung compliance, and others6
have reported that pediatric patients with tetralogy of Fallot
corrected at a later age (2 to 12 years) had decreased lung
compliance and vital capacity compared with those who
had undergone correction at an earlier age (<2 years). Our
data would support the former, with surgical intervention
at a young age clearly associated with a greater prevalence
of RLF. Those with the earliest interventions, before 1
month of age, did not seem to have risk additional to
that of those who had undergone intervention by 1 year
of age.
It would be expected that those with more severe forms
of structural CHD would be recognized and surgically
repaired at an earlier age and would undergo more
complex, multistage procedures. The severity of CHD
might to some extent be associated with the development
of RLF. This theory was supported by our findings that
RLF prevalence was greater with surgical intervention at
an earlier age, with the combination of sternotomy and
thoracotomy at the initial intervention, and after multiple
interventions. That no difference was found when
comparing sternotomy and thoracotomy alone, or when
comparing surgical intervention before 1 month of age
with intervention before 1 year of age, speaks against210 The Journal of Thoracic and Cardiovascular SurgCHD severity as the sole cause. The most severe forms
of CHD would be expected to require intervention before
1 month of age, although this is not absolute. However, in
a heterogeneous population such as ours, with many
forms of CHD, comparing the severity of 1 form to
another would be difficult or impractical owing to the
considerable physiologic differences.
Fredrisken and colleagues5 suggested diaphragmatic
palsy, a restrictive thoracic cage, and/or respiratory
muscle weakness as possible etiologies of postoperative
RLF development, although they showed no effect of
the interval since repair and had only 12 months of
follow-up data. It has been speculated that thoracotomy
would be less likely to lead to diaphragmatic palsy and
therefore would not lead to the same risk of RLF that
sternotomy carries. However, repeated interventions of
either type might convey similar risk. A restrictive
thoracic cage is a highly suspected etiology, because
this could be caused by a number of factors, including
scarring of the chest wall, release of inflammatory medi-
ators that might lead to scarring of the pleural surface, and
a decreased range of motion of the costovertebral joints,
either from inflammation or disuse in the postoperative
period. Cardiopulmonary bypass has been associated
with the release of proinflammatory mediators and with
increased pulmonary vascular resistance, in particular.21
Much like in our study, it remains unclear whether it is
causality or simply association. To our knowledge, ours
is the only study that compared the prevalence of RLF
after thoracotomy to sternotomy and demonstrated no
evidence of difference when stratified by these surgical
approaches. Given the significant differences in manipula-
tion of the pleural surfaces and scarring that occur during
sternotomy and thoracotomy, the common aspects of
surgical intervention must be considered as possible
factors leading to RLF, such as operation time, length of
mechanical ventilation, need for pain management,
prolonged periods of hypoventilation, length of hospital
stay, and length of recovery.
Our study was limited by its retrospective nature. Ideally,
wewould prospectivelymonitor pulmonary function testing
in patients with particular forms of CHD. The patients with
RLF did not undergo lung volume assessment, which would
be necessary to confirm restrictive lung disease instead of a
pattern of RLF. Also, there is the question of the clinical
relevance of RLF without knowledge of patient symptoms.
All patients involved presented for CPET because of
symptoms; however, the severity and limitation of those
symptoms were not evaluated. Also, the lack of a significant
number of patients with spirometry obtained both before
and after surgical intervention also limits the application
of our findings. The inability to perform spirometry before
early surgical repair of the more severe forms of CHD
leaves the question of how CHD severity affects theery c July 2014
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Ddevelopment of RLF unanswered. Obtaining infant pulmo-
nary function testing would be ideal but is likely impractical
in this population, for whom surgical intervention is
performed urgently and/or very early in life.
Finally, the control population might not represent a
‘‘healthy’’ population, because those referred for CPET
might have had symptoms because of some other etiology,
albeit not of cardiac origin. Although these controls
might not provide a truly representative indication of
RLF prevalence, we have postulated that those referred
for CPET for any reason would be more likely to
have pathophysiologic features, including restrictive lung
disease, and would make our findings even more pertinent
if compared with a normal population.
We have concluded that surgical intervention is associ-
ated with the development of RLF in pediatric patients
with structural CHD, regardless of the underlying CHD
lesion. The prevalence of RLF increased if the initial
intervention involved both sternotomy and thoracotomy,
was performed at a younger age, and was followed by
additional surgical interventions. The CHD severity might
contribute to these findings. Pulmonary function testing
for all those who have undergone any form of thoracic
surgical intervention should be routinely performed.
More research is needed in this field, in particular, of
possible mechanisms for postoperative thoracic restriction
and the comparison of pre- and postoperative pulmonary
function testing in the pediatric CHD population. This
might become more feasible as infant pulmonary function
testing evolves.
We would like to thank Emmie Altepeter, Cristine Martinez,
and Robert R. Wolfe, MD, for their assistance in data collection
and manuscript development.
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